No “Wearing‐Off Effect” Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long‐Term Study

OBJECTIVE: To evaluate whether quarterly or monthly administration of fremanezumab for migraine prevention exhibits a pattern of decreased efficacy toward the end of the dosing interval (wearing‐off effect). BACKGROUND: The main goals of migraine preventive treatment are to reduce the frequency, sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Blumenfeld, Andrew M., Stevanovic, Darko M., Ortega, Mario, Cohen, Joshua M., Seminerio, Michael J., Yang, Ronghua, Jiang, Bo, Tepper, Stewart J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756709/
https://www.ncbi.nlm.nih.gov/pubmed/33009665
http://dx.doi.org/10.1111/head.13994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756709/
https://www.ncbi.nlm.nih.gov/pubmed/33009665
http://dx.doi.org/10.1111/head.13994

Ejemplares similares